Table 2.

HIV and infectious morbidity. HIV: human immunodeficiency virus; AIDS: acquired immunodeficiency syndrome; HAART: highly active antiretroviral therapy; AZT: zidovudine; INH: isoniazide; PACTG: the Pediatric AIDS Clinical Trials Group; TB: tuberculosis; S/P: status-post.

Patient	Prepregnancy therapy	Initial viral load (copies/mL)	Initial CD4 count (abs/mm3)	Gestational	Antepartum therapy	Vaginal	Viral coinfections	PPD status
				age at		infections
				initiations		in this
				of HAART		pregnancy
1	None	2672	508	None	AZT	Trichomonas	None	Negative
						C trachomatis
						Gonorrhea
2	None	179	858	15 0/7	Combivir	None	None	Negative
					Neviripine
3	Neviripine	< 50	684	15 3/7	Neviripine	None	Hepatitis A	Positive, s/p
	Lamivudine				Lamivudine			INH
	Stavudine				Stavudine			prophylaxis
4	Combivir	< 50	407	13 0/7	Combivir	None	None	Negative
					Neviripine
5	None	971	312	14 0/7	Combivir	Trichomonas	None	Negative
6	None	N/A	766	None	(Placebo	None	None	Negative
					arm of
					PACTG
					076)
7	AZT	N/A	N/A	None	AZT	Trichomonas	Hepatitis C	h/o TB, s/p
								therapy